DK0624098T3 - Fremgangsmåde til konjugering af antivirale nukleosider med lactosamineret humant albumin - Google Patents

Fremgangsmåde til konjugering af antivirale nukleosider med lactosamineret humant albumin

Info

Publication number
DK0624098T3
DK0624098T3 DK94901834T DK94901834T DK0624098T3 DK 0624098 T3 DK0624098 T3 DK 0624098T3 DK 94901834 T DK94901834 T DK 94901834T DK 94901834 T DK94901834 T DK 94901834T DK 0624098 T3 DK0624098 T3 DK 0624098T3
Authority
DK
Denmark
Prior art keywords
pct
human albumin
conjugating
hsa
antiviral
Prior art date
Application number
DK94901834T
Other languages
English (en)
Inventor
Luigi Fiume
Corrado Busi
Stefano Giuseppina Di
Alessandro Mattioli
Original Assignee
Baldacci Lab Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baldacci Lab Spa filed Critical Baldacci Lab Spa
Application granted granted Critical
Publication of DK0624098T3 publication Critical patent/DK0624098T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/643—Albumins, e.g. HSA, BSA, ovalbumin or a Keyhole Limpet Hemocyanin [KHL]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
DK94901834T 1992-11-23 1993-11-20 Fremgangsmåde til konjugering af antivirale nukleosider med lactosamineret humant albumin DK0624098T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI922673A IT1256110B (it) 1992-11-23 1992-11-23 Procedimento di coniugazione di nucleosidi antivirali con albumina umana lattosaminata
PCT/EP1993/003261 WO1994012218A1 (en) 1992-11-23 1993-11-20 Process of conjugation of antiviral nucleosides with lactosaminated human albumin

Publications (1)

Publication Number Publication Date
DK0624098T3 true DK0624098T3 (da) 2000-06-05

Family

ID=11364330

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94901834T DK0624098T3 (da) 1992-11-23 1993-11-20 Fremgangsmåde til konjugering af antivirale nukleosider med lactosamineret humant albumin

Country Status (11)

Country Link
US (1) US5594110A (da)
EP (1) EP0624098B1 (da)
AT (1) ATE190504T1 (da)
AU (1) AU5626294A (da)
DE (1) DE69328082T2 (da)
DK (1) DK0624098T3 (da)
ES (1) ES2144046T3 (da)
GR (1) GR3033611T3 (da)
IT (1) IT1256110B (da)
PT (1) PT624098E (da)
WO (1) WO1994012218A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5632915A (en) * 1994-08-29 1997-05-27 Gerber Garment Technology, Inc. Laser material processing apparatus and a work table therefor
US5693791A (en) * 1995-04-11 1997-12-02 Truett; William L. Antibiotics and process for preparation
US20020099013A1 (en) * 2000-11-14 2002-07-25 Thomas Piccariello Active agent delivery systems and methods for protecting and administering active agents
US8394813B2 (en) 2000-11-14 2013-03-12 Shire Llc Active agent delivery systems and methods for protecting and administering active agents
ITMI20010027A1 (it) * 2001-01-10 2002-07-10 Uni Di Bologna Dipartimento Di Composizioni teraputiche per una chemioterapia locoregionale non invasiva delle micrometastasi epatiche
US7169752B2 (en) * 2003-09-30 2007-01-30 New River Pharmaceuticals Inc. Compounds and compositions for prevention of overdose of oxycodone
US20060014697A1 (en) * 2001-08-22 2006-01-19 Travis Mickle Pharmaceutical compositions for prevention of overdose or abuse
CN106008699A (zh) 2006-09-08 2016-10-12 Ambrx公司 经修饰的人类血浆多肽或Fc骨架和其用途
PT2419732T (pt) * 2009-04-15 2019-12-24 Abraxis Bioscience Llc Composições e métodos de nanopartículas isentas de priões
US9534243B2 (en) 2013-02-07 2017-01-03 The United States Of America, As Represented By The Secretary Of Commerce Nucleotide analogs and process for making same enzyme

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1177381B (it) * 1984-12-11 1987-08-26 Baldacci Lab Spa Metodo per la preparazione di coniugati della adenina-9-beta-d-arabino furano-side 5' monofosfato con albumina umana lattosaminata, coniugati risultanti e relative composizioi terapeuticamente attive
IT1207507B (it) * 1985-10-21 1989-05-25 Baldacci Lab Spa Coniugato della 9-(2-idrossietossimetil)guanina con albumina umana lattosaminata, procedimento per la sua preparazione e composizioni farmaceutiche che la contengono.

Also Published As

Publication number Publication date
WO1994012218A1 (en) 1994-06-09
IT1256110B (it) 1995-11-28
DE69328082D1 (de) 2000-04-20
EP0624098B1 (en) 2000-03-15
US5594110A (en) 1997-01-14
ITMI922673A0 (it) 1992-11-23
ATE190504T1 (de) 2000-04-15
PT624098E (pt) 2000-08-31
GR3033611T3 (en) 2000-10-31
EP0624098A1 (en) 1994-11-17
ES2144046T3 (es) 2000-06-01
AU5626294A (en) 1994-06-22
ITMI922673A1 (it) 1994-05-23
DE69328082T2 (de) 2000-08-24

Similar Documents

Publication Publication Date Title
DE69633332D1 (de) Alpha-substituierte pyrimidin-thioalkylderivate und alkylether als inhibitoren viraler reverser transkriptfase
ATE219765T1 (de) Indolderivate als cgmp-pde inhibitoren
ES2086376T3 (es) Nucleosidos pirimidinicos antivirales.
DK0624098T3 (da) Fremgangsmåde til konjugering af antivirale nukleosider med lactosamineret humant albumin
ATE92326T1 (de) Adenosin-deaminase-stabile anti-retroviralnukleoside.
CA2215190A1 (en) Aryl-ester phosphoramidate derivatives of nucleosides
NO307407B1 (no) Morfinpreparat med kontrollert frigjøring
EA200100298A1 (ru) ФАРМАЦЕВТИЧЕСКИЕ ПРЕПАРАТЫ С РЕГУЛИРУЕМЫМ ВЫСВОБОЖДЕНИЕМ, СОДЕРЖАЩИЕ ИНГИБИТОР cGMP-ФОСФОДИЭСТЕРАЗЫ-5
ES2091689T3 (es) Aplicacion de la carbamazepina y de la oxcarbazepina en el tratamiento de la enfermedad de parkinson y de los sindromes parkinsonianos.
DK92788A (da) Anvendelse af 3'-deoxy-3'-flourguanosider til fremstilling af laegemidler mod retrovira
TR199901433T2 (xx) Pirolo$3,4-D] pirimidinon t�revleri ve bunlar�n ila� olarak kullan�mlar�.
TR200001519T2 (tr) İnsanlardaki Spermatozoa'nın konsantrasyonu ve/veya hareket kabiliyetini artırmak için uygulanması gerekli yöntem ve ilaç terkipleri
TR200001869T2 (tr) Terapetik Maddeler
NO953878D0 (no) Umettede fosfonatderivater av puriner og pyrimidiner
DK0686155T3 (da) Xanthinderivater som adenosin A1-receptor-antagonister
DK0625158T3 (da) Terapeutiske nucleosider af 2',3'-dideoxy-3'-fluorpurinrækken
MY105855A (en) Therapeutic nucleotides.
FR2700166B1 (fr) Dérivés de pyrrolidine, leur préparation et les médicaments les contenant.
TR199801069T2 (xx) Trisiklik 1,4-dihidro-1,4-diokso-1H-naftalen t�revleri ve bunlar�n terap�tik kullan�m�
IT1244873B (it) Derivati dell'acido 5-aminosalicilico (5-asa) per la terapia delle infiammazioni croniche intestinali
ES2149817T3 (es) Piridinas sustituidas, su preparacion y uso farmaceutico.
WO1990005523A3 (en) Phenanthrolinedicarboxylate esters, 4-aminoquinoline and isoquinoline derivatives as inhibitors of hiv reverse transcriptase
PT958290E (pt) Derivados de 1,4-di-hidropiridina e seu uso em terapia
FR2693195B1 (fr) Dérivés de 2-amino-N-[[[(4-aminocarbonyl)pyrimidin-2-yl]amino]alkyl] pyrimidine-4-carboxamide, leur préparation et leur application en thérapeutique.
FR2699171B1 (fr) Dérivés de 2-amino-N[[[4-aminocarbonyl) pyrimidin-2-yl]amino]alkyl]pyrimidine-4-carboxamide, leur préparation et leur application en thérapeutique.